Tumour budding and its clinical implications in gastrointestinal cancers.

Zlobec, Inti; Berger, Martin D.; Lugli, Alessandro (2020). Tumour budding and its clinical implications in gastrointestinal cancers. British journal of cancer, 123(5), pp. 700-708. Nature Publishing Group 10.1038/s41416-020-0954-z

Preview

Text s41416-020-0954-z.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Note: This work is published under the standard license to publish agreement. After12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0). Download (910kB) | Preview

Tumour budding in colorectal cancer has become an important prognostic factor. Represented by single cells or small tumour cell clusters at the invasion front of the tumour mass, these tumour buds seem to reflect cells in a 'hybrid' state of epithelial-mesenchymal transition, and evidence indicates that the presence of these entities is associated with lymph node metastasis, local recurrence and distant metastatic disease. The International Tumour Budding Consensus Conference (ITBCC) has highlighted a scoring system for the reporting of tumour budding in colorectal cancer, as well as different clinical scenarios that could affect patient management. Other organs are not spared: tumour budding has been described in numerous gastrointestinal and non-gastrointestinal cancers. Here, we give an update on ITBCC validation studies in the context of colorectal cancer and the clinical implications of tumour budding throughout the upper gastrointestinal and pancreatico-biliary tract.

Interest & Impact

Downloads

114 since deposited on 26 Aug 2020
36 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item